PAPER Feng SM, Che CH, Feng SY, Liu CY, Li LY, Li YX, Huang HP, Zou ZY
SEARCH RESULTS
18781 RESULTS
PAPER Goodman LD, Bonini NM
New Roles for Canonical Transcription Factors in Repeat Expansion Diseases.
Trends Genet. 2020 Feb;36(2):81-92. Epub 2019 Dec 11 PubMed: 31837826PAPER Stamm BC, Lao PJ, Rizvi B, Colon J, Igwe K, Chesebro AG, Maas B, Schupf N, Mayeux R, Manly JJ, Brickman AM
Parental history of dementia is associated with increased small vessel cerebrovascular disease.
J Gerontol A Biol Sci Med Sci. 2019 Dec 15; PubMed: 31838489PAPER El-Sayed NF, El-Hussieny M, Ewies EF, Fouad MA, Boulos LS
New phosphazine and phosphazide derivatives as multifunctional ligands targeting acetylcholinesterase and β-Amyloid aggregation for treatment of Alzheimer's disease.
Bioorg Chem. 2020 Jan;95:103499. Epub 2019 Dec 6 PubMed: 31838287PAPER Simrén J, Ashton NJ, Blennow K, Zetterberg H
An update on fluid biomarkers for neurodegenerative diseases: recent success and challenges ahead.
Curr Opin Neurobiol. 2020 Apr;61:29-39. Epub 2019 Dec 13 PubMed: 31838254PAPER Forouzannezhad P, Abbaspour A, Li C, Fang C, Williams U, Cabrerizo M, Barreto A, Andrian J, Rishe N, Curiel RE, Loewenstein D, Duara R, Adjouadi M
A Gaussian-based model for early detection of mild cognitive impairment using multimodal neuroimaging.
J Neurosci Methods. 2020 Mar 1;333:108544. Epub 2019 Dec 12 PubMed: 31838182PAPER Lin FY, Lin YF, Lin YS, Yang CM, Wang CC, Hsiao YH
Relative D3 vitamin deficiency and consequent cognitive impairment in an animal model of Alzheimer's disease: Potential involvement of collapsin response mediator protein-2.
Neuropharmacology. 2020 Mar 1;164:107910. Epub 2019 Dec 12 PubMed: 31838171PAPER Li A, Zhao J, Fan C, Zhu L, Huang C, Li Q, Gan D, Wen C, Chen M, Lu D
Delivery of exogenous proteins by mesenchymal stem cells attenuates early memory deficits in a murine model of Alzheimer's disease.
Neurobiol Aging. 2020 Feb;86:81-91. Epub 2019 Dec 11 PubMed: 31837910PAPER Samaridou E, Walgrave H, Salta E, Álvarez DM, Castro-López V, Loza M, Alonso MJ
Nose-to-brain delivery of enveloped RNA- cell permeating peptide nanocomplexes for the treatment of neurodegenerative diseases.
Biomaterials. 2020 Feb;230:119657. Epub 2019 Dec 6 PubMed: 31837821PAPER Coppola C, Oliva M, Saracino D, Pappatà S, Zampella E, Cimini S, Ricci M, Giaccone G, Di Iorio G, Rossi G
One novel GRN null mutation, two different aphasia phenotypes.
Neurobiol Aging. 2020 Mar;87:141.e9-141.e14. Epub 2019 Nov 12 PubMed: 31837909Deann Dickinson
Spokane, United States
Genomics of Brain Disorders (Virtual Meeting)
CONFERENCE 2021-04-14 00:00:00-2021-04-16 00:00:00 Hinxton, England 14 April 2021 to 16 April 2021 View Conference Website 1
Lauren Massimo
University of Pennsylvania
Jon Turner
PAPER Gartlehner G, Hansen RA, Morgan LC, Thaler K, Lux LJ, Van Noord M, Mager U, Strobelberger M, Gaynes BN, Thieda P, Lloyd S, Reichenpfader U, Lohr KN
Second-Generation Antidepressants in the Pharmacologic Treatment of Adult Depression: An Update of the 2007 Comparative Effectiveness Review [Internet].
Rockville (MD): Agency for Healthcare Research and Quality (US); 2011 Dec. Report No.: 12-EHC012-EF. AHRQ Comparative Effectiveness Reviews.Current Filters
- Date Range : Oct 2019 to Oct 2020 x